UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Discover when it’s advisable to keep cash instead of opting for bank deposits. This information will help you manage your money wisely.
23,560 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Tuesday brought a notable rally in Honeywell shares as the company outlined a stand-alone path for Quantinuum. This a...
This in-depth analysis dives into the implications of the Netskope Q1 2027 earnings transcript for investors. Learn t...
A dramatic earnings miss sent EHang stocks lower, highlighting the challenges facing early-stage eVTOL developers. Th...
Despite a chorus of buy ratings on Shopify, a dissenting view flags limited upside as AI tools and monetization effor...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
Electric-vehicle names rise as a broad tech rebound fuels gains; Tesla jumps 8%, Rivian and Lucid climb about 7% in a...
SpaceX shares moved lower even as a wave of bullish analyst initiations hit the tape. The sector’s rhythm remains vol...
JEPQ offers monthly income via a covered-call strategy, but five-year performance trails uncapped NASDAQ exposure. Th...
When a feud becomes a marketing engine, money talks louder than records. This feature examines how T.I. targets Cent ...
As Omada Health eyes the 2025 earnings journey, investors want a clear read on growth, margins, and risks. This guide...
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...